Abstract | BACKGROUND: AIM: SETTING AND DESIGN: This was a pilot, randomized, open-label trial conducted at a tertiary level hospital from November 2012 to March 2014. MATERIALS AND METHODS: Children aged 3 months to 3 years presenting with infantile spasms in clusters (at least 1 cluster/day) with hypsarrhythmia or its variants on electroencephalogram (EEG) were enrolled. The study participants were randomized to receive either oral prednisolone (4 mg/kg/day) alone or 30 mg/kg/day of pyridoxine with oral prednisolone. The primary outcome measure was the proportion of children who achieved spasm freedom for 48 h on day-14 after treatment initiation, as per parental reports, in both the groups. The adverse effects were also monitored. The study was registered with clinicaltrials.gov (ClinicalTrials.gov Identifier: NCT01828437). RESULTS: Sixty-two children were randomized into the two groups with comparable baseline characteristics. The proportion of children with spasm cessation on day-14 was similar in the two groups (39 vs. 37%, P = 0.98). The adverse effects were comparable in both the groups. CONCLUSIONS:
|
Authors | Vedavathi Kunnanayaka, Puneet Jain, Suvasini Sharma, Anju Seth, Satinder Aneja |
Journal | Neurology India
(Neurol India)
2018 Mar-Apr
Vol. 66
Issue 2
Pg. 385-390
ISSN: 0028-3886 [Print] India |
PMID | 29547159
(Publication Type: Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Anti-Inflammatory Agents
- Drug Combinations
- Vitamin B Complex
- Prednisolone
- Pyridoxine
|
Topics |
- Anti-Inflammatory Agents
(therapeutic use)
- Child, Preschool
- Drug Combinations
- Electroencephalography
- Female
- Follow-Up Studies
- Humans
- Infant
- Male
- Outcome Assessment, Health Care
- Pilot Projects
- Prednisolone
(therapeutic use)
- Pyridoxine
(therapeutic use)
- Retrospective Studies
- Spasms, Infantile
(drug therapy)
- Vitamin B Complex
(therapeutic use)
|